Unveiling Atherosclerotic Plaque Heterogeneity and SPP1+/VCAN+ Macrophage Subtype Prognostic Significance Through

Xiang Xu1,2, Fuling Qiu2, Man Yang3

  • 1School of Medicine, Yunnan University, Kunming City, Yunnan Province, People's Republic of China.

PubMed
Abstract

Insights

This study reveals distinct atherosclerosis plaque subtypes and identifies specific macrophage subtypes (SPP1+/VCAN+, IL1B+, FLT3LG+) linked to poor prognosis and increased immune infiltration, offering new diagnostic biomarkers.

Area of Science:

  • Cardiovascular Biology
  • Immunology
  • Genomics

Background:

  • Dysregulated macrophages contribute significantly to atherosclerosis (AS) development and plaque instability.
  • The intricate heterogeneity of atherosclerotic plaques and the precise roles of macrophage subtypes in driving plaque instability remain incompletely understood.

Purpose of the Study:

  • To comprehensively analyze atherosclerotic plaque heterogeneity using integrated single-cell and bulk sequencing data.
  • To elucidate the functional roles and prognostic significance of diverse macrophage subtypes in AS progression and plaque instability.

Main Methods:

  • Integrated single-cell and bulk sequencing data analysis.
  • Unsupervised clustering for plaque subtype identification, survival analysis, and gene set variation analysis (GSVA).
  • Differential expression of macrophage genes (DEMGs) score, pseudo-trajectory analysis, CellChat, and BayesPrism for cell interaction and differentiation analysis.

Main Results:

  • Identified three distinct AS plaque subtypes, with cluster 3 exhibiting high immune infiltration and poor prognosis.
  • Elevated DEMGs scores in SPP1+/VCAN+, IL1B+, and FLT3LG+ macrophage subtypes correlated with cluster 3 and poorer outcomes.
  • Macrophage differentiation trajectories revealed a 'Cell fate 2' state dominant in these subtypes, associated with adverse clinical events and distinct cellular interactions.

Conclusions:

  • Provides a detailed map of AS plaque heterogeneity and the prognostic implications of specific macrophage subtypes.
  • Highlights the clinical relevance of macrophage subtypes, particularly SPP1+/VCAN+ macrophages, in AS progression and plaque instability.
  • Identified potential diagnostic biomarkers for AS through machine learning and validated their relevance.